# MyStart
# LLM discovery file
# Generated 2026-04-20T22:33:41.283Z

> MyStart is a GLP-1 program information site focused on semaglutide, tirzepatide, provider review, and the path from intake to delivery.

## Important Notice
Medical eligibility, diagnosis, prescribing, and treatment decisions are made by licensed healthcare providers after review of the intake and any required follow-up.

## Key Pages
- [Home](https://trymystarthealth.com/)
- [Solutions](https://trymystarthealth.com/solutions)
- [Topic Hubs](https://trymystarthealth.com/hub)
- [Methodology](https://trymystarthealth.com/methodology)
- [Editorial Policy](https://trymystarthealth.com/editorial-policy)
- [Evidence Review Policy](https://trymystarthealth.com/medical-review-policy)
- [Evidence Review Team](https://trymystarthealth.com/medical-reviewers)
- [Authors](https://trymystarthealth.com/authors)
- [About](https://trymystarthealth.com/about)
- [Privacy Policy](https://trymystarthealth.com/privacy)
- [Terms of Service](https://trymystarthealth.com/terms)

## Solutions
- [Semaglutide Through MyStart](https://trymystarthealth.com/solutions/semaglutide-access)
- [Tirzepatide Through MyStart](https://trymystarthealth.com/solutions/tirzepatide-access)

## Topic Hubs
- [How MyStart Works](https://trymystarthealth.com/hub/how-glp1-access-works)
- [Semaglutide vs Tirzepatide](https://trymystarthealth.com/hub/medication-pathways)
- [Pricing, Eligibility, and Disclosures](https://trymystarthealth.com/hub/cost-eligibility-and-safety)

## Profiles
- [MyStart Editorial Team](https://trymystarthealth.com/authors/mystart-editorial-team)
- [MyStart Evidence Review Team](https://trymystarthealth.com/medical-reviewers/mystart-evidence-review-team)

## Crawl and Index Signals
- [Sitemap](https://trymystarthealth.com/sitemap.xml)